Clinical Trial Update: Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ultraviolet light therapy using methoxsalen with or without bexarotene for mycosis fungoides; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Non-hodgkin Lymphoma

Drugs mentioned

• Bexarotene (Bexarotene)
• Methoxsalen (Methoxsalen)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lymphoma | Phase 3 | Status: TERMINATED